argyrotsipi/train-dataset huggingface dataset:
Engagements — House of Commons, 2018-10-24
Topic: Defense
Questions: If music be the food of love, we could certainly do with a lot of music just now. In that regard, will my right hon. Friend join me in welcoming Sir Michael Parkinson having opened the expanded premises of the United Kingdom’s first jazz centre in Southend on Saturday, inspired by Digby Fairweather and displaying wonderful jazz memorabilia and music—and is that not yet another reason why Southend should be declared a city?; Belmont and Betteridge special schools do a fantastic job of educating children with special educational needs in my constituency, but over the past decade they have had to contend with an explosion in pupil complexity—emotional, behavioural and medical. Does the Prime Minister agree that we need a careful examination of what lies behind such seismic changes so that we can deliver the best possible outcomes for all our children for years to come?
Theresa Mary May (Conservative, Centre-right): We are concerned about the humanitarian issues in Yemen. We are actually the third largest humanitarian donor to Yemen, where we have provided significant support to millions of men, women and children. I remind the right hon. Gentleman that, yes, we do support the Saudi-led coalition’s military intervention in Yemen, which has been recognised by the United Nations Security Council and came at the request of the legitimate President Hadi On defence exports, the procedures we follow are among the strictest in the world. They were introduced in 2000 by the late Robin Cook, and they were updated in 2014 by the Conservative-led coalition Government to reflect our obligations under the arms trade treaty. A licence will not be issued to Saudi Arabia or any other destination if to do so would be inconsistent with any provision of the consolidated EU and national arms export licensing criteria. In July 2017 the High Court ruled that our sales to Saudi Arabia were compliant with those regulations, but of course we keep things under review.
Northern Ireland (Executive Formation and Exercise of Functions) Bill — House of Commons, 2018-10-24
Topic: Defense
Michael Penning (Conservative, Centre-right): I completely agree with the hon. Lady. Sinn Féin see their people who were doing those atrocities as combatants. They were part of their army; that is why they called them what they did. But they do not look at our veterans in the same way; actually, I think they look at them with derision. I served with Catholics from Belfast in the Army, and they could not go home—certainly, if they did, they could not tell anyone what they were doing. When I was in basic training, many of them stayed with me, with us, because they felt that they could not go back, even though they were Unionists and they wanted to serve in the British Army. Many people from the south served in the British Army. We have police officers from the Republic now who are serving in the police force in Northern Ireland. That is the sort of thing we had, but we still do not have peace What peace do we have in Northern Ireland? We have touched on this, and on the murders of prison officers. When I was the Minister there, David Black was shot with a weapon that most people in Northern Ireland know was an AK47, from the Gaddafi era, that was supposed to have been placed out of use and out of everything. He was shot on the M1 going to work. What sort of peace is that?
Northern Ireland (Executive Formation and Exercise of Functions) Bill — House of Commons, 2018-10-24
Topic: Defense
Michael Penning (Conservative, Centre-right): Perhaps unusually, I agree with my right hon. Friend on nearly everything she says apart from her point about the Attorney General. British soldiers who were there to keep the peace—that is what I was sent to do—were sent by the British Government and so, in my opinion, the only Attorney General who should look at it is the Attorney General here. We were sent there not by Northern Ireland Ministers or Attorney Generals, but by those who were here. My Prime Minister at the time sent the troops. I went in ’74; there were lots before me and lots after us. It cannot be right—it cannot—that this Bill ignores what was given by so many to protect the Province.
Northern Ireland (Executive Formation and Exercise of Functions) Bill — House of Commons, 2018-10-24
Topic: Defense
Michael Penning (Conservative, Centre-right): I will not give way, because the Deputy Speaker has already told me off once, but I will conclude I fundamentally think I was sent to this place to do a job—to protect my constituents and look after them, after they have looked after us. If this House is not willing to protect veterans who served in Northern Ireland, I am afraid I cannot support the Bill.
Northern Ireland (Executive Formation and Exercise of Functions) Bill — House of Commons, 2018-10-24
Topic: Health
Fiona Claire Bruce (Conservative, Centre-right): No. I have taken several interventions, and I will, if I may, proceed New clause 7 goes much further even than the non-binding comments made by the judges in the Supreme Court case—a case of serious foetal abnormality. As I say, I am mindful of what a difficult situation that is and fully agree that it merits further attention for the women who may be affected by it, but that must happen in the right legislative chamber.
Northern Ireland (Executive Formation and Exercise of Functions) Bill — House of Commons, 2018-10-24
Topic: Health
Michael Penning (Conservative, Centre-right): I do not understand why Hart has not been done. There was huge courage within the Northern Ireland Health Department when we got medical cannabis for constituents in Northern Ireland when we were getting Billies and Alfies over here. People had the will and they needed the confidence. Is my hon. Friend sure that this legislation will give them the confidence, because clearly they are frightened and something is holding them back? They have done it for medical cannabis, so surely they could do it for Hart.
Northern Ireland (Executive Formation and Exercise of Functions) Bill — House of Commons, 2018-10-24
Topic: Health
Andrew William Murrison (Conservative, Centre-right): I am not really sure that that is the case. I refer the hon. Gentleman to the guidance, which I am sure he has now read. On the third page, the guidance states that particular weight must be given to any "serious detriment to the public interest, public health and wellbeing" That seems fairly clearcut to me. I think that the Secretary of State will have got the sense of the House today on her being proactive in the guidance that she is able to issue.
Northern Ireland (Executive Formation and Exercise of Functions) Bill — House of Commons, 2018-10-24
Topic: Health
Andrew William Murrison (Conservative, Centre-right): I do understand that. One point I made on Second Reading was that I was slightly disappointed that the Bill does not advance pretty much any of the recommendations we made in our report on the democratic deficit, published in May. Had it done so, there would be scope now for even more consultation, using formal structures, which may have assisted the implementation to which the hon. Lady rightly refers My right hon. Friend the Member for Hemel Hempstead (Sir Mike Penning) mentioned cannabis, which leads me on to healthcare—a matter that is of particular importance to my Committee right now, since we were at the Royal Victoria Hospital on Monday, where we took evidence from a number of service users. It is very clear from the guidance, which cites public interest and public health, that this matter is preying on the mind of Ministers. It is a crying shame that there is no proper cancer strategy in Northern Ireland right now. There is one published in 2008, so it is out of date. We have a situation where, to pick one condition at random, the outcomes for prostate cancer are far worse in Northern Ireland than in the rest of the country. This is pretty clear. If we do not have a cancer strategy and we believe that a cancer strategy will be of assistance in improving outcomes, of course outcomes will be worse if one is not in place. To get a cancer strategy, we need some form of direction to civil servants to get on with it and, furthermore, to implement it.
Northern Ireland (Executive Formation and Exercise of Functions) Bill — House of Commons, 2018-10-24
Topic: Health
Andrew William Murrison (Conservative, Centre-right): The hon. Gentleman is absolutely right. I do not want to labour the point, but I feel the need to briefly mention the fact that screening for cancer in Northern Ireland is frankly woeful—it is way behind. We cannot have a situation where there is faecal immunochemical testing in the rest of the UK, but it is denied to people in Northern Ireland, and they also cannot get HPV screening for cervical cancer. That is just not acceptable. But for these things to happen, we need some form of direction, however it comes, and that is a matter for Ministers and those who draft measures of the sort we are discussing and, of course, those who deal with the consequentials of the guidance that we are dealing with.
Northern Ireland (Executive Formation and Exercise of Functions) Bill — House of Commons, 2018-10-24
Topic: Defense
Michael Penning (Conservative, Centre-right): One of the powers of this House and the Government relates to those who are becoming victims—the veterans. If an amendment were tabled in the other place that actually protected our veterans for their service, would the Government oppose that?
Gay Conversion Therapy — House of Commons, 2018-06-07
Topic: Health
Questions: To ask the right hon. Member for Meriden, representing the Church Commissioners, what recent discussions the Church of England has had with Government Ministers on the General Synod’s resolution on gay conversion therapy; and if she will make a statement.
Caroline Alice Spelman (Conservative, Centre-right): I am grateful to the right hon. Gentleman, because this allows me to update the House on the similar question that he asked me in January. I did follow my promise to write to the Under-Secretary of State for Health and Social Care, my hon. Friend the Member for Thurrock (Jackie Doyle-Price), who has responsibility for mental health, and arrange a meeting with her, which was constructive—the right hon. Gentleman came with me. She explained that the Department is surveying the extent of gay conversion therapy. I wrote to her again on 23 April requesting a copy of that Government survey, so that we might all benefit from their findings.
Privilege — House of Commons, 2018-06-07
Topic: Defense
Julian Murray Lewis (Conservative, Centre-right): I endorse what the hon. Gentleman has just said. The same applies to senior officials. The Defence Committee very nearly got to the point of issuing a summons, but common sense broke through. The Government, whether Ministers or senior officials, are required to set a good example.
Privilege — House of Commons, 2018-06-07
Topic: Defense
Julian Murray Lewis (Conservative, Centre-right): May I just say to my hon. Friend in her role as Chairman of the Liaison Committee that she was enormously helpful to the Defence Committee—as were other members of the Committee—in getting the senior official to agree to come, and in getting the Prime Minister to agree to his attending the Defence Committee? In the end, it was a very valuable session. I do not know Mr Cummings, but I support his cause, and he is in danger of doing grave damage to the cause that he and I both support because the effect of his refusal is far more damaging than anything that could happen at a hearing if he actually gave evidence. Finally, may I appeal to her to stop using the word "backstop", which, at the moment, is not my favourite expression?
Tuberculosis — House of Commons, 2018-06-07
Topic: Health
Nick Herbert (Conservative, Centre-right): I strongly agree with the hon. Gentleman that the diseases must be treated together. However, great progress has been made on tackling AIDS, partly because of the tremendous new tools available. By comparison, less progress has been made on tuberculosis. Last year, 1.7 million people died of tuberculosis. That is more than AIDS and malaria combined. The single fact that most people do not realise is that tuberculosis is now the world’s deadliest infectious disease, and it deserves more attention than it gets. Some 10 million people globally are falling ill each year as a result of this disease TB was declared a global health emergency by the World Health Organisation 24 years ago. Since then, 54 million people have died. That is not a great advert for the declaration of a global health emergency. Three years ago in New York, the world’s leaders set the sustainable development goals. Target 3.3 was to eliminate these major epidemics in 15 years. At the current trajectory, TB will not be eliminated for 160 years, so another 28 million people will die in the sustainable development goal period alone, costing the world economy $1 trillion cumulatively. Middle and lower-income countries will be the most severely hit, with lower-income countries experiencing a reduction of something like 2% of their GDP On top of this, there are new threats. I mentioned that TB strikes when immune systems are compromised, and they can be compromised in new ways, including by the acquisition of diabetes. In Indonesia, TB is striking people with diabetes, which is a growing problem Above all—this should concern the House greatly—is the growing risk of drug resistance. TB is the only major drug resistant infection that is transmitted through the air. It is already responsible for one in three deaths worldwide from all forms of drug resistance. Drug resistance generally now kills 700,000 people a year, but Lord O’Neill’s commission, set up by David Cameron, predicted that drug resistance would kill 10 million people a year by 2050, and that those deaths would fall in the west and advanced economies, not just in poor and middle-income ones. That compares with, for instance, 8 million deaths a year from cancer. We are talking about catastrophic loss and catastrophic economic cost, with a cumulative GDP loss of $100 trillion, knocking 2% to 3.5% off global GDP. It is significant that a quarter of those deaths from antimicrobial resistance would be due to tuberculosis, which is already responsible for a third of antimicrobial resistance deaths; that is 200,000 deaths a year.
Tuberculosis — House of Commons, 2018-06-07
Topic: Health
Nick Herbert (Conservative, Centre-right): That is a very interesting point. TB is a disease of poverty. This opportunistic infection will strike if there are no basic health systems and if nutrition and housing are poor, and all those conditions would probably exist in areas of conflict Drug-resistant TB is a terrible affliction. It can be dealt with, but even in an advanced healthcare system, it requires a course of treatment in which some 14,000 pills have to be taken. This treatment is appalling, as it can cause patients to become deaf and creates a lot of suffering. Only half of drug-resistant TB patients are successfully treated. In fact, there is a lower survival rate for drug-resistant TB than for lung cancer.
Tuberculosis — House of Commons, 2018-06-07
Topic: Health
Nick Herbert (Conservative, Centre-right): Again, I do agree. The scale of TB in London makes it one of the TB capitals of Europe. We have some 5,000 cases of TB in the UK. That figure is coming down with the new public health strategy, but it is still too high. The right hon. Gentleman is right. This disease is easily and cheaply curable, and it has been since the discovery of antibiotics, so why are we not doing it?
Tuberculosis — House of Commons, 2018-06-07
Topic: Health
Sarah James (Wollaston) (Conservative, Centre-right): I thank my right hon. Friend for his very powerful speech. Further to his points about the importance of public health, would he urge the Government, in their future strategy, to make sure that we look at NHS public health and social care as part of a single system?
Tuberculosis — House of Commons, 2018-06-07
Topic: Health
Nick Herbert (Conservative, Centre-right): Yes. My hon. Friend is probably aware that there is a collaborative TB strategy that was introduced by the Government, urged by the all-party parliamentary group on global TB, which the hon. Member for Ealing, Southall and I co-chair. That strategy shows very promising signs. It represents exactly the kind of partnership that we need between Public Health England and NHS England. I commend the Government for having introduced that partnership Most people do not realise that there is no vaccine for tuberculosis. There is a child vaccine, BCG, that some of us had when we were young, but there is no adult vaccine that works for tuberculosis—and no epidemic in human history has been beaten without a vaccine. The reason there is no vaccine is that there is market failure. Unlike HIV/AIDS, this is primarily a disease of the poor. With HIV/AIDS, there were people dying in western countries as well. The pharmaceutical companies do not have a commercial incentive to invest in the new tools that we need—better drugs, better diagnostics and a vaccine. Without partnership funding that comes from the Government, and Governments around the world who can afford it, we will not develop these new tools and we will not beat TB in the requisite timeframe.
Tuberculosis — House of Commons, 2018-06-07
Topic: Health
Jeremy John Elton Lefroy (Conservative, Centre-right): I thank my right hon. Friend for all the work he does on TB. As chair of the all-party parliamentary group on malaria and neglected tropical diseases, I would like to point out that there is a malaria vaccine, which is being deployed for the first time. We are not sure how effective it is. It is clearly quite effective, but a lot more work needs to be done on it. Companies such as GSK, which is behind this vaccine, are prepared to invest in these things even though they have no commercial return from them. Let us hope that a similar approach will be taken by commercial companies and Governments in respect of TB.
Tuberculosis — House of Commons, 2018-06-07
Topic: Health
Nick Herbert (Conservative, Centre-right): I agree that some companies are willing to take a non-commercial view, such as Johnson & Johnson and Osaka Pharmaceuticals, but many other major pharmaceutical companies are not developing new TB tools because there is no commercial incentive. Therefore, we do need that partnership funding to make this happen I would argue that there are three powerful reasons for us to act: a humanitarian reason because of the number of deaths, an economic reason because of the cost to the global economy of not doing so, and a global health security reason because of the risk of drug resistance.
Tuberculosis — House of Commons, 2018-06-07
Topic: Health
Nick Herbert (Conservative, Centre-right): My understanding is that they already do. That is a good example of how we already—although we need to do more—deploy the resources that are available to us. Indeed, the commitment that we make as the second biggest donor to the Global Fund to Fight AIDS, Tuberculosis and Malaria—£1.2 billion in the last replenishment—has been made possible because of the increase in aid spending and the target that has been set At last, this disease is commanding greater political attention. It has got on to the G7 and G20 agenda, partly because of the lobbying that is being done by the Global TB Caucus, which I co-chair with South Africa’s Health Minister, and now numbers 2,500 parliamentarians in 130 countries. In November, there was a WHO ministerial summit in Moscow. In February, Prime Minister Modi of India announced a TB strategy Above all, there is a reason to be optimistic because, at the United Nations on 26 September, there will be, for the first time ever, a high-level meeting on tuberculosis that it is intended that Heads of Government and Heads of State will attend, where a new declaration will be launched, with a commitment by the world’s leaders to act. That has to address the current funding gap whereby we are $6 billion a year short of the funding needed properly to eliminate TB by the SDG deadline in 15 years’ time. It also has to introduce greater accountability so that Governments are locked into proper targets to ensure that they really do reduce TB. In addition, there needs to be a dramatic increase in research and development to develop the new tools that I mentioned. All this requires leadership.
Tuberculosis — House of Commons, 2018-06-07
Topic: Health
Nick Herbert (Conservative, Centre-right): This has a been a good debate, with a large degree of consensus across the House and many well-informed contributions from right hon. and hon. Members on both sides, including the Front Benchers. I am grateful for that and for the help that hon. Members are giving to raise the profile of this disease I pay tribute to the work of the co-chair of the all-party group on global tuberculosis, the hon. Member for Ealing, Southall (Mr Sharma). He was expecting to speak, but was taken away from the House for something else. However, I am sure that he would have wanted to draw attention to the huge progress being made in India, where the Prime Minister, as I mentioned earlier, has shown real leadership by getting India to commit to eliminate TB on a tighter timescale than the one in the sustainable development goals. That has shown the kind of global leadership that will be necessary, and if we can encourage other global leaders to follow that lead, we will make huge progress. I congratulate the Government on what they have been doing. I accept the Minister’s description of all the things that DFID and other Departments are doing, and I note that the International Development and Health Secretaries have personally committed to the issue, for which I am grateful TB has been the orphan disease. Despite its terrible record of claiming lives, it does not have the celebrity champions or the pop stars of other diseases, and it does not get the same media attention. Although the disease claims more lives every year than any other infectious disease, I can guarantee that the media will pay no attention whatsoever to this debate. That needs to come to an end. Today, we in this House have at least played our part in raising the profile of the disease, helping to make TB truly a disease of the past Question put and agreed to. Resolved, That this House recognises that tuberculosis (TB) remains the world’s deadliest infectious disease, killing 1.7 million people a year; notes that at the current rate of progress, the world will not reach the Sustainable Development Goal target of ending TB by 2030 for another 160 years; believes that without a major change of pace 28 million people will die needlessly before 2030 at a global economic cost of £700 billion; welcomes the forthcoming UN high-level meeting on TB in New York on 26 September as an unprecedented opportunity to turn the tide against this terrible disease; further notes that the UN General Assembly Resolution encourages all member states to participate in the high-level meeting at the highest possible level, preferably at the level of heads of state and government; and calls on the Government to renew its efforts in the global fight against TB, boost research into new drugs, diagnostics and a vaccine, and for the Prime Minister to attend the UN high-level meeting.
Prayers — House of Commons, 2018-10-26
Topic: Health
John Simon Bercow (Conservative, Centre-right): I hope that the appetite has now been satisfied and we can proceed with alacrity to business Bill Presented Healthcare (International Arrangements) Presentation and First Reading (Standing Order No. 57) Secretary Matt Hancock, supported by the Prime Minister, Secretary Dominic Raab, Secretary Esther McVey, Secretary Jeremy Wright and Stephen Barclay, presented a Bill to make provision about paying and arranging for healthcare provided outside the United Kingdom and giving effect to healthcare arrangements; and for connected purposes Bill read the First time; to be read a Second time tomorrow, and to be printed (Bill 279) with explanatory notes (Bill 279-EN).